Archive for May 2019
Václav Potěšil, PhD
Václav first investigated machine learning & medical imaging to help doctors diagnose cancer a decade before it became practical. He holds a M.Phil from the University of Cambridge, funded by Microsoft Research, and a Doctorate (D.Phil) from the University of Oxford supervised by Prof. Sir Mike Brady and Dr. Timor Kadir, based at Siemens Molecular…
Read MoreLyn Baranowski
Lyn Baranowski is the COO of Altavant Sciences. She has significant experience in the respiratory therapeutic area leading commercial, transactional, financial and strategic functions. This experience spans roles in multiple biotech companies (Pearl Therapeutics and Melinta Therapeutics), big pharma (Novartis) and venture capital (Vatera Healthcare), giving Ms. Baranowski a unique perspective on how to build…
Read MoreJohn Lord, PhD
Dr. Lord serves as Head of Research and Development and is responsible for directing and overseeing all aspects of the development lifecycle for programs within the company’s portfolio. He has more than 26 years of inhalation product development experience including leadership roles at pharmaceutical companies like Rhône-Poulenc Rorer and Nektar Therapeutics. He has experience across…
Read MoreJohn A. Belperio, MD
Dr. John Belperio is an associate professor of pulmonary and critical care medicine at the David Geffen School of Medicine at UCLA and an expert on lung disease, lung transplants and the respiratory system.
Read More